Novel patented SRC kinase inhibitor.

@article{Lu2012NovelPS,
  title={Novel patented SRC kinase inhibitor.},
  author={Xiao-ling Lu and Xiao-Yu Liu and Xin Cao and Bing-hua Jiao},
  journal={Current medicinal chemistry},
  year={2012},
  volume={19 12},
  pages={
          1821-9
        }
}
Src family of protein tyrosine kinases (SFKs) plays key roles in the regulation of signal transductions in cellular processes. However, hyper-activated SFKs lead to uncontrolled cell proliferation and cancers. Src-targeted compounds were developed to block the cell proliferation signal transductions for cancer therapy. Src kinase domain inhibitors were… CONTINUE READING